Equillium, Inc. (EQ) Social Stream
Equillium Inc (EQ) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering EQ.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 4 | $18 | $12 | $13.6 | $3.29 | 313.37% |
| 2022-01-05 | 5 | $18 | $12 | $13.6 | $3.29 | 313.37% |
| 2022-01-12 | 5 | $14 | $12 | $12.8 | $3.29 | 289.06% |
The Trend in the Analyst Price Target
Over the past 130 days, EQ's average price target has gone down $1.2.
Over the past 40 weeks, EQ's average upside potential has been 153.21%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-21 | 3 | 21 | 12 | 15.6 | 5.91 | 163.96% |
| 2021-09-19 | 4 | 18 | 12 | 14.0 | 6.38 | 119.44% |
| 2021-10-29 | 5 | 18 | 12 | 13.6 | 6.31 | 115.53% |
| 2021-11-15 | 5 | 18 | 12 | 13.6 | 5.61 | 142.42% |
| 2021-12-13 | 5 | 18 | 12 | 13.6 | 4.65 | 192.47% |
EQ Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 31 days, EQ's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EQ as an investment opportunity.
- In the context of all US stocks, Equillium Inc's upside potential (average analyst target price relative to current price) is higher than 278.83% of them.
- In terms of how Equillium Inc fares relative to all US stocks, note that its average analyst price target is higher than 40.53% of that group.
- In terms of how Equillium Inc fares relative to stocks in the micro market cap category, note that its number of analysts covering the stock is greater than 251.41% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Equillium Inc's variance in analysts' estimates is lower than 14.54% of them.
Stocks similar to Equillium Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ENVB, ENLV, and EDSA.
Is EQ a Buy, Hold or Sell? See the POWR Ratings now!